ABM Respiratory Care Secures $20 Million for Growth and Innovation in Respiratory Solutions

ABM Respiratory Care Scores $20 Million Investment

ABM Respiratory Care, a pioneering name in medical technology, has recently announced securing a substantial financing round, raising $20 million from Trinity Capital Inc. This investment is aimed at facilitating significant commercial growth as ABMRC positions itself as a leader in innovative respiratory care solutions tailored for both hospital and home environments.

The financing from Trinity Capital, a notable alternative asset manager, is set to propel ABMRC into its next phase of expansion. The company plans to refine its market presence across existing and new territories while focusing on advancing product innovation and clinical research.

Greg Miller, ABMRC's Chief Executive Officer, emphasized the strategic importance of this partnership. He stated, "This financing represents an important milestone in ABM Respiratory Care's continued growth. Our partnership with Trinity Capital provides additional capital and flexibility to expand our commercial reach, build on the momentum of our BiWaze platform, and invest in technologies that support the evolving needs of patients and healthcare providers worldwide."

The BiWaze® Platform: A Technological Breakthrough

Central to ABMRC's offerings is the BiWaze® platform, which encompasses two FDA-cleared respiratory therapy systems designed to meet specific airway clearance requirements:

1. BiWaze® Clear: This system delivers oscillating lung expansion therapy specifically engineered to mobilize secretions and support airway clearance within the lower airways.
2. BiWaze® Cough: Providing mechanical insufflation-exsufflation therapy, this technology assists patients suffering from ineffective coughs in their efforts to clear secretions.

Designed for versatility, these systems are applicable in both hospital settings and home care environments, allowing for a seamless transition in patient care. Alongside these innovations, ABMRC is actively working to expand the commercial accessibility of its technologies while enhancing clinical research efforts.

Digital Health Integration with Arc Connect™

In addition to advancing physical technology, ABM Respiratory Care is also focused on enhancing patient engagement through its Arc Connect™ digital health platform. This innovative system is designed to facilitate therapy tracking and provide care teams with enhanced visibility into respiratory therapy utilization. It contrasts ABMRC's commitment to not just patient care but also to the overall wellness of healthcare providers who utilize their systems.

Trinity Capital's Senior Managing Director for Healthcare & Life Sciences, Rob Lake, expressed optimism regarding the collaboration: "We are pleased to partner with ABM Respiratory Care as the company enters its next phase of growth. We believe in the company's technology and its vision for expanding access to respiratory care solutions."

A Vision for the Future

Founded in 2017, ABM Respiratory Care has a clear mission: to transform patient care by delivering intelligent, clinically advanced respiratory solutions that help individuals breathe better whether they are in a clinical or home setting. With the financial backing of Trinity Capital, ABMRC is poised to significantly enhance its innovative efforts.

The company’s platform not only emphasizes advanced therapies but also enhances overall disease management by facilitating deeper breathing, improving oxygen exchange, and minimizing aerosol emissions. ABMRC’s commitment to integrating these advancements reflects a broader trend in healthcare technology where connectivity and efficacy are at the forefront.

For more information on ABM Respiratory Care and its commitment to improving respiratory health, you can visit www.abmrc.com.

Conclusion

With a robust financial investment and a clear strategy for growth, ABM Respiratory Care is on the cusp of making significant improvements in respiratory health both inside and outside hospital environments. As they journey forward, the collaboration with Trinity Capital underscores the vital intersection of innovative technology and strategic investment in enhancing healthcare solutions for patients around the world.